Emergent BioSolutions Inc (EBS)
1.915
+0.02
(+0.79%)
USD |
NYSE |
Apr 18, 14:01
Emergent BioSolutions Total Return Level: 1.90 for April 17, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 17, 2024 | 1.90 |
April 16, 2024 | 1.95 |
April 15, 2024 | 1.98 |
April 12, 2024 | 2.06 |
April 11, 2024 | 2.19 |
April 10, 2024 | 2.23 |
April 09, 2024 | 2.31 |
April 08, 2024 | 2.32 |
April 05, 2024 | 2.29 |
April 04, 2024 | 2.27 |
April 03, 2024 | 2.26 |
April 02, 2024 | 2.16 |
April 01, 2024 | 2.30 |
March 28, 2024 | 2.53 |
March 27, 2024 | 2.59 |
March 26, 2024 | 2.44 |
March 25, 2024 | 2.54 |
March 22, 2024 | 2.41 |
March 21, 2024 | 2.47 |
March 20, 2024 | 2.51 |
March 19, 2024 | 2.46 |
March 18, 2024 | 2.47 |
March 15, 2024 | 2.45 |
March 14, 2024 | 2.35 |
March 13, 2024 | 2.24 |
Date | Value |
---|---|
March 12, 2024 | 2.33 |
March 11, 2024 | 2.80 |
March 08, 2024 | 2.69 |
March 07, 2024 | 2.77 |
March 06, 2024 | 3.26 |
March 05, 2024 | 3.41 |
March 04, 2024 | 3.17 |
March 01, 2024 | 3.39 |
February 29, 2024 | 3.23 |
February 28, 2024 | 3.20 |
February 27, 2024 | 3.30 |
February 26, 2024 | 2.85 |
February 23, 2024 | 2.74 |
February 22, 2024 | 2.80 |
February 21, 2024 | 2.71 |
February 20, 2024 | 1.52 |
February 16, 2024 | 1.56 |
February 15, 2024 | 1.70 |
February 14, 2024 | 1.69 |
February 13, 2024 | 1.59 |
February 12, 2024 | 1.80 |
February 09, 2024 | 1.58 |
February 08, 2024 | 1.68 |
February 07, 2024 | 1.50 |
February 06, 2024 | 1.56 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.50
Minimum
Feb 07 2024
134.94
Maximum
Aug 13 2020
44.91
Average
44.54
Median
Total Return Level Benchmarks
Avid Bioservices Inc | 6.71 |
Viking Therapeutics Inc | 66.54 |
FibroGen Inc | 1.26 |
Avinger Inc | 3.67 |
RAPT Therapeutics Inc | 8.02 |